DR. JOHN ZANELLA, MD
Anesthesiologist Assistant at Nonconnah Blvd, Memphis, TN

2009026, Oct 22, 2009

Apr 18, 2008

12/105474

John ZANELLA - Memphis TN, US

Warsaw Orthopedic, Inc. - Warsaw IN

A61K 9/14, A61K 31/135, A61P 29/00, A61K 31/192

424490, 514646, 514569

Effective treatments of acute pain and/or inflammation for extended periods of time are provided. Through the administration of an effective amount of sulfasalazine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.

7993666, Aug 9, 2011

Apr 18, 2008

12/105809

William McKay - Memphis TN, US
John Zanella - Memphis TN, US

Warsaw Orthopedic, Inc. - Warsaw IN

A61K 9/14, A61K 9/00, A61K 31/351, A61K 31/21, A61K 31/404, A61K 31/435, A61K 31/40, A61K 31/47, A61K 31/505

424424, 424489, 514460, 514529, 514419, 514277, 514423, 514311, 514275

Methods and compositions are provided for reducing, treating or preventing pain and/or inflammation in a patient in need of such treatment, the methods and compositions comprising administering a therapeutically effective amount of a statin or pharmaceutically acceptable salt thereof to a target tissue site beneath the skin.

2009026, Oct 22, 2009

Apr 18, 2008

12/105375

Stephen M. Cox - Minneapolis MN, US
Christopher M. Hobot - Minneapolis MN, US
John M. Zanella - Memphis TN, US
Vanja M. King - Memphis TN, US
William F. McKay - Memphis TN, US
Kathy L. Remsen - Memphis TN, US

Warsaw Orthopedic, Inc. - Warsaw IN

A61K 31/4402, A61P 29/00

514352

Effective treatments of acute pain and/or inflammation for extended periods of time are provided. Through the administration of an effective amount of sulfasalazine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.

8524267, Sep 3, 2013

Apr 18, 2008

12/105864

John Zanella - Memphis TN, US
Vanja King - Memphis TN, US
Christopher M. Hobot - Memphis TN, US
Stephen M. Cox - Inver Grove Heights MN, US
William McKay - Memphis TN, US
Kathy Remsen - Memphis TN, US

Warsaw Orthopedic, Inc. - Warsaw IN

A61F 2/00, A61K 9/00

424426

Effective treatments of acute pain for extended periods of time are provided. Through the administration of an effective amount of dexamethasone at or near a target site, one can relieve pain cause by diverse sources, including but not limited to spinal disc herniation (i. e. sciatica), spondilothesis, stenosis, discongenic back pain and joint pain as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least twenty-five days. In some embodiments, the relief can be for at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.

8557271, Oct 15, 2013

Jul 16, 2008

12/174007

Toya D. Kimble - Memphis TN, US
Susan J. Drapeau - Memphis TN, US
William F. McKay - Memphis TN, US
John Myers Zanella - Memphis TN, US
Erica Tenbroek - Minneapolis MN, US

Warsaw Orthopedic, Inc. - Warsaw IN

A61K 9/24, A61P 29/00, A61P 25/00

424423

Methods and compositions for treating a tissue within a synovial joint in a patient in need of such treatment are provided. The methods and compositions involve inserting a drug depot through the synovial joint and attaching the drug depot to the inside of the synovial joint capsule so that the drug depot does not substantially interfere with movement of the joint, wherein said depot comprises a polymer and at least one pharmaceutical agent.

2006004, Mar 2, 2006

Sep 2, 2004

10/932878

William McKay - Memphis TN, US
John Zanella - Memphis TN, US

A61K 38/17

514012000

The invention provides a method for alleviating pain associated with neuromuscular or skeletal injury or inflammation by controlled and directed delivery of one or more biological response modifiers to inhibit the inflammatory response which ultimately causes acute or chronic pain. Controlled and directed delivery can be provided by implantable or infusion pumps, implantable controlled release devices, or by sustained release compositions comprising biological response modifiers.